55 related articles for article (PubMed ID: 9537256)
1. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.
Matsubara A; Kan M; Feng S; McKeehan WL
Cancer Res; 1998 Apr; 58(7):1509-14. PubMed ID: 9537256
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis.
Zhang Y; Wang H; Toratani S; Sato JD; Kan M; McKeehan WL; Okamoto T
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11336-40. PubMed ID: 11562460
[TBL] [Abstract][Full Text] [Related]
3. HiFENS: high-throughput FISH detection of endogenous pre-mRNA splicing isoforms.
Shilo A; Pegoraro G; Misteli T
Nucleic Acids Res; 2022 Dec; 50(22):e130. PubMed ID: 36243969
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the
Teles SP; Oliveira P; Ferreira M; Carvalho J; Ferreira P; Oliveira C
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31881796
[TBL] [Abstract][Full Text] [Related]
5. Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2.
Lee JE; Shin SH; Shin HW; Chun YS; Park JW
Sci Rep; 2019 Mar; 9(1):3480. PubMed ID: 30837551
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer.
Wang C; Liu Z; Ke Y; Wang F
Front Genet; 2019; 10():12. PubMed ID: 30761180
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor Family in the Progression of Prostate Cancer.
Teishima J; Hayashi T; Nagamatsu H; Shoji K; Shikuma H; Yamanaka R; Sekino Y; Goto K; Inoue S; Matsubara A
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30720727
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.
Akl MR; Nagpal P; Ayoub NM; Tai B; Prabhu SA; Capac CM; Gliksman M; Goy A; Suh KS
Oncotarget; 2016 Jul; 7(28):44735-44762. PubMed ID: 27007053
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factors, old kids on the new block.
Li X; Wang C; Xiao J; McKeehan WL; Wang F
Semin Cell Dev Biol; 2016 May; 53():155-67. PubMed ID: 26768548
[TBL] [Abstract][Full Text] [Related]
10. Potential prognostic and diagnostic application of a novel monoclonal antibody against keratinocyte growth factor receptor.
Ceccarelli S; Bei R; Vescarelli E; D'Amici S; di Gioia C; Modesti A; Romano F; Redler A; Marchese C; Angeloni A
Mol Biotechnol; 2014 Oct; 56(10):939-52. PubMed ID: 24899248
[TBL] [Abstract][Full Text] [Related]
11. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.
Finch PW; Mark Cross LJ; McAuley DF; Farrell CL
J Cell Mol Med; 2013 Sep; 17(9):1065-87. PubMed ID: 24151975
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.
Redler A; Di Rocco G; Giannotti D; Frezzotti F; Bernieri MG; Ceccarelli S; D'Amici S; Vescarelli E; Mitterhofer AP; Angeloni A; Marchese C
PLoS One; 2013; 8(8):e72224. PubMed ID: 23977259
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
14. Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.
Holzmann K; Grunt T; Heinzle C; Sampl S; Steinhoff H; Reichmann N; Kleiter M; Hauck M; Marian B
J Nucleic Acids; 2012; 2012():950508. PubMed ID: 22203889
[TBL] [Abstract][Full Text] [Related]
15. The receptor tyrosine kinase FGFR2b/KGFR controls early differentiation of human keratinocytes.
Belleudi F; Purpura V; Torrisi MR
PLoS One; 2011; 6(9):e24194. PubMed ID: 21957444
[TBL] [Abstract][Full Text] [Related]
16. FGFR3-expressing smooth muscle-like stromal cells differentiate in response to FGFR2IIIb-expressing prostate tumor cells and delay tumor progression.
Jin C; Yang C; Wu X; Wang F; McKeehan WL
In Vitro Cell Dev Biol Anim; 2011 Aug; 47(7):500-5. PubMed ID: 21691921
[TBL] [Abstract][Full Text] [Related]
17. FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells.
Kobayashi M; Huang Y; Jin C; Luo Y; Okamoto T; Wang F; McKeehan WL
Prostate; 2011 Nov; 71(15):1691-700. PubMed ID: 21446013
[TBL] [Abstract][Full Text] [Related]
18. Novel phosphotyrosine targets of FGFR2IIIb signaling.
Luo Y; Yang C; Jin C; Xie R; Wang F; McKeehan WL
Cell Signal; 2009 Sep; 21(9):1370-8. PubMed ID: 19410646
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.
Gartside MG; Chen H; Ibrahimi OA; Byron SA; Curtis AV; Wellens CL; Bengston A; Yudt LM; Eliseenkova AV; Ma J; Curtin JA; Hyder P; Harper UL; Riedesel E; Mann GJ; Trent JM; Bastian BC; Meltzer PS; Mohammadi M; Pollock PM
Mol Cancer Res; 2009 Jan; 7(1):41-54. PubMed ID: 19147536
[TBL] [Abstract][Full Text] [Related]
20. Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
Oltean S; Febbo PG; Garcia-Blanco MA
Clin Exp Metastasis; 2008; 25(6):611-9. PubMed ID: 18523850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
